These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32123296)

  • 1. Association of MICA-129Met/Val polymorphism with clinical outcome of anti-TNF therapy and MICA serum levels in patients with rheumatoid arthritis.
    Iwaszko M; Świerkot J; Dratwa M; Wysoczańska B; Korman L; Bugaj B; Kolossa K; Jeka S; Wiland P; Bogunia-Kubik K
    Pharmacogenomics J; 2020 Dec; 20(6):760-769. PubMed ID: 32123296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association study of MICA gene polymorphisms with rheumatoid arthritis susceptibility in south Tunisian population.
    Achour Y; Kammoun A; Ben Hamad M; Mahfoudh N; Chaabane S; Marzouk S; Keskes L; Gaddour L; Bahloul Z; Maalej A
    Int J Immunogenet; 2014 Dec; 41(6):486-92. PubMed ID: 25256191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of MICA-129 polymorphism and circulating soluble MICA level with rheumatoid arthritis in a south Indian Tamil population.
    Mariaselvam CM; Boukouaci W; Charron D; Krishnamoorthy R; Tamouza R; Misra DP; Negi VS
    Int J Rheum Dis; 2018 Mar; 21(3):656-663. PubMed ID: 28752674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of MICA with rheumatoid arthritis independent of known HLA-DRB1 risk alleles in a family-based and a case control study.
    Kirsten H; Petit-Teixeira E; Scholz M; Hasenclever D; Hantmann H; Heider D; Wagner U; Sack U; Hugo Teixeira V; Prum B; Burkhardt J; Pierlot C; Emmrich F; Cornelis F; Ahnert P
    Arthritis Res Ther; 2009; 11(3):R60. PubMed ID: 19409079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of MICA and NKG2D genetic variants with disease susceptibility and outcome of anti-TNF therapy in patients with axial spondyloarthritis.
    Wielińska J; Bugaj B; Świerkot J; Kolossa K; Iwaszko M; Jeka S; Bogunia-Kubik K
    Clin Exp Rheumatol; 2024 Jul; 42(7):1359-1367. PubMed ID: 38372728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the MICA polymorphism in systemic lupus erythematosus.
    Yoshida K; Komai K; Shiozawa K; Mashida A; Horiuchi T; Tanaka Y; Nose M; Hashiramoto A; Shiozawa S
    Arthritis Rheum; 2011 Oct; 63(10):3058-66. PubMed ID: 21702010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MICA-129 Dimorphism and Soluble MICA Are Associated With the Progression of Multiple Myeloma.
    Zingoni A; Vulpis E; Cecere F; Amendola MG; Fuerst D; Saribekyan T; Achour A; Sandalova T; Nardone I; Peri A; Soriani A; Fionda C; Mariggiò E; Petrucci MT; Ricciardi MR; Mytilineos J; Cippitelli M; Cerboni C; Santoni A
    Front Immunol; 2018; 9():926. PubMed ID: 29765374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms within the human leucocyte antigen-E gene and their associations with susceptibility to rheumatoid arthritis as well as clinical outcome of anti-tumour necrosis factor therapy.
    Iwaszko M; Świerkot J; Kolossa K; Jeka S; Wiland P; Bogunia-Kubik K
    Clin Exp Immunol; 2015 Dec; 182(3):270-7. PubMed ID: 26307125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of polymorphisms in TRAILR1 and TNFR1A on the response to anti-TNF therapies in patients with rheumatoid and psoriatic arthritis.
    Morales-Lara MJ; Cañete JD; Torres-Moreno D; Hernández MV; Pedrero F; Celis R; García-Simón MS; Conesa-Zamora P
    Joint Bone Spine; 2012 Dec; 79(6):591-6. PubMed ID: 22480748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MICA-129Met/Val dimorphism affects plasma membrane expression and shedding of the NKG2D ligand MICA.
    Isernhagen A; Schilling D; Monecke S; Shah P; Elsner L; Walter L; Multhoff G; Dressel R
    Immunogenetics; 2016 Feb; 68(2):109-23. PubMed ID: 26585323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replication of association of the PTPRC gene with response to anti-tumor necrosis factor therapy in a large UK cohort.
    Plant D; Prajapati R; Hyrich KL; Morgan AW; Wilson AG; Isaacs JD; ; Barton A
    Arthritis Rheum; 2012 Mar; 64(3):665-70. PubMed ID: 21952740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Combined Transcriptomic and Genomic Analysis Identifies a Gene Signature Associated With the Response to Anti-TNF Therapy in Rheumatoid Arthritis.
    Aterido A; Cañete JD; Tornero J; Blanco F; Fernández-Gutierrez B; Pérez C; Alperi-López M; Olivè A; Corominas H; Martínez-Taboada V; González I; Fernández-Nebro A; Erra A; López-Lasanta M; López Corbeto M; Palau N; Marsal S; Julià A
    Front Immunol; 2019; 10():1459. PubMed ID: 31312201
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetic variants in NKG2D axis and susceptibility to Epstein-Barr virus-induced nasopharyngeal carcinoma.
    Viet NH; Trung NQ; Dong LT; Trung LQ; Espinoza JL
    J Cancer Res Clin Oncol; 2021 Mar; 147(3):713-723. PubMed ID: 33392659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of variants of Fc gamma receptors IIA and IIIA on the American College of Rheumatology and European League Against Rheumatism responses to anti-tumour necrosis factor alpha therapy in rheumatoid arthritis.
    Cañete JD; Suárez B; Hernández MV; Sanmartí R; Rego I; Celis R; Moll C; Pinto JA; Blanco FJ; Lozano F
    Ann Rheum Dis; 2009 Oct; 68(10):1547-52. PubMed ID: 18930989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MICA-129Met/Val Polymorphism Is Associated with Early-Onset Breast Cancer Risk.
    Ouni N; Ben Chaaben A; Kablouti G; Lajnef M; Ayari F; Abaza H; Damak T; Harzallah L; Benammar-Elgaaeid A; Guemira F; Tamouza R
    Immunol Invest; 2017 Aug; 46(6):603-614. PubMed ID: 28742417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of CD94 and NKG2A variants on susceptibility to rheumatoid arthritis and efficacy of anti-TNF treatment.
    Iwaszko M; Świerkot J; Kolossa K; Jeka S; Wiland P; Bogunia-Kubik K
    Joint Bone Spine; 2016 Jan; 83(1):75-9. PubMed ID: 26453102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the MICA-129Met/Val Dimorphism on NKG2D-Mediated Biological Functions and Disease Risks.
    Isernhagen A; Malzahn D; Bickeböller H; Dressel R
    Front Immunol; 2016; 7():588. PubMed ID: 28018354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotype at the sIL-6R A358C polymorphism does not influence response to anti-TNF therapy in patients with rheumatoid arthritis.
    Hassan B; Maxwell JR; Hyrich KL; ; Barton A; Worthington J; Isaacs JD; Morgan AW; Wilson AG
    Rheumatology (Oxford); 2010 Jan; 49(1):43-7. PubMed ID: 19926672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of rheumatoid arthritis susceptibility genes identifies association of AFF3 and CD226 variants with response to anti-tumour necrosis factor treatment.
    Tan RJ; Gibbons LJ; Potter C; Hyrich KL; Morgan AW; Wilson AG; Isaacs JD; ; Barton A
    Ann Rheum Dis; 2010 Jun; 69(6):1029-35. PubMed ID: 20444755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of anti-CCP positivity and carriage of TNFRII susceptibility variant with anti-TNF-α response in rheumatoid arthritis.
    Vasilopoulos Y; Bagiatis V; Stamatopoulou D; Zisopoulos D; Alexiou I; Sarafidou T; Settas L; Sakkas L; Mamouris Z
    Clin Exp Rheumatol; 2011; 29(4):701-4. PubMed ID: 21813066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.